What is Heart Failure with Mid-range Ejection Fraction? A New Subgroup of Patients with Heart Failure

Sunil K Nadar1, Osama Tariq1

  • 1Sultan Qaboos University Hospital Muscat, Oman.

Insights

Heart failure with mildly reduced ejection fraction (HFmrEF) is a newly defined class. This review clarifies the clinical characteristics and pathophysiology of HFmrEF patients, previously a grey area in heart failure research.

Area of Science:

  • Cardiology
  • Heart Failure Research

Background:

  • The 2016 European Society of Cardiology guidelines introduced heart failure with mildly reduced ejection fraction (HFmrEF).
  • HFmrEF represents a previously under-defined group between HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF).
  • Patients in this intermediate category were often excluded from studies or misclassified.

Purpose of the Study:

  • To define and characterize the newly recognized HFmrEF patient group.
  • To explore the clinical characteristics and pathophysiology of HFmrEF.
  • To consolidate existing literature on this specific heart failure classification.

Main Methods:

  • Literature review and synthesis.
  • Analysis of existing research on HFmrEF.
  • Clarification of diagnostic criteria and patient profiles.

Main Results:

  • HFmrEF bridges the gap between HFrEF and HFpEF.
  • This classification allows for targeted research into a distinct patient population.
  • Understanding HFmrEF characteristics is crucial for future treatment strategies.

Conclusions:

  • The establishment of HFmrEF provides a framework for dedicated research.
  • Further investigation into HFmrEF pathophysiology and treatment is warranted.
  • This classification improves the precision of heart failure diagnosis and management.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
978
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.9K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
927
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
368
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
990
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
342